Causeway Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-522,030
Closed -$6.91M 107
2024
Q4
$6.91M Sell
522,030
-759,162
-59% -$10.1M 0.16% 71
2024
Q3
$18.2M Sell
1,281,192
-72,972
-5% -$1.04M 0.45% 52
2024
Q2
$17.5M Sell
1,354,164
-90,744
-6% -$1.17M 0.48% 54
2024
Q1
$20.1M Buy
1,444,908
+99,263
+7% +$1.38M 0.52% 51
2023
Q4
$19.2M Buy
1,345,645
+101,336
+8% +$1.45M 0.49% 52
2023
Q3
$19.2M Buy
1,244,309
+123,725
+11% +$1.91M 0.51% 50
2023
Q2
$17.6M Sell
1,120,584
-8,782
-0.8% -$138K 0.46% 49
2023
Q1
$18.6M Sell
1,129,366
-200,676
-15% -$3.31M 0.45% 46
2022
Q4
$20.7M Sell
1,330,042
-100,663
-7% -$1.57M 0.6% 40
2022
Q3
$18.6M Sell
1,430,705
-76,118
-5% -$987K 0.52% 45
2022
Q2
$21.2M Sell
1,506,823
-94,223
-6% -$1.32M 0.53% 44
2022
Q1
$22.9M Buy
1,601,046
+91,897
+6% +$1.32M 0.55% 41
2021
Q4
$20.6M Sell
1,509,149
-397,849
-21% -$5.42M 0.45% 47
2021
Q3
$31.2M Sell
1,906,998
-124,266
-6% -$2.04M 0.7% 40
2021
Q2
$34.2M Buy
2,031,264
+357,809
+21% +$6.02M 0.7% 43
2021
Q1
$30.6M Buy
1,673,455
+129,284
+8% +$2.36M 0.6% 42
2020
Q4
$28.1M Buy
1,544,171
+65,647
+4% +$1.19M 0.53% 45
2020
Q3
$26.4M Sell
1,478,524
-61,855
-4% -$1.1M 0.49% 43
2020
Q2
$27.6M Sell
1,540,379
-632,986
-29% -$11.3M 0.5% 42
2020
Q1
$33M Sell
2,173,365
-328,931
-13% -$4.99M 0.53% 40
2019
Q4
$49.4M Sell
2,502,296
-26,204
-1% -$517K 0.53% 40
2019
Q3
$43.5M Sell
2,528,500
-19,240
-0.8% -$331K 0.52% 35
2019
Q2
$45.1M Buy
2,547,740
+159,387
+7% +$2.82M 0.49% 37
2019
Q1
$48.7M Buy
2,388,353
+183,969
+8% +$3.75M 0.49% 35
2018
Q4
$37.1M Buy
+2,204,384
New +$37.1M 0.44% 38